A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer.
Ann Surg Treat Res
; 105(6): 360-368, 2023 Dec.
Article
em En
| MEDLINE
| ID: mdl-38076600
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Ann Surg Treat Res
Ano de publicação:
2023
Tipo de documento:
Article